AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that mediates potent anti-tumor activity, cytotoxicity, and expansion of memory CD8+ T cells

AB821 - Asher Biotherap

https://jitc.bmj.com/content/10/Suppl_2/A1123

Renee Greer 1; Henry Nguyen 1; Paul Mesko 1; Ruth Lan 1; Wei Wei Prior 1; Hussein Sultan 2; Meghana Sukthankar 1; Irene Ni 1; S Michael Chin 1; Kelly Moynihan 1; Ton Schumacher 3; Robert Schreiber 2; Andy Yeung 1; Ivana Djuretic 1

Oct 6, 2022